BRS201

DRUG3 trials

Sponsors

Brigham and Women's Hospital

Conditions

Primary Sclerosing CholangitisUlcerative ColitisUlcerative Colitis Chronic ModerateUlcerative Colitis Chronic SevereUlcerative Colitis Mild

Phase 2

Detoxification of the Liver In PSC (Dolphin)

RecruitingNCT05835505

Brigham and Women's HospitalPrimary Sclerosing Cholangitis

Start: 2023-12-12End: 2027-06-01Target: 28Updated: 2026-07-21

Study of Novel Therapeutics for Acute Remedy of Colitis

RecruitingNCT06420492

Brigham and Women's HospitalUlcerative Colitis, Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic Severe

Start: 2025-09-30End: 2027-06-01Target: 20Updated: 2025-10-17

Treatment of UC With Novel Therapeutics

RecruitingNCT06420375

Brigham and Women's HospitalUlcerative Colitis, Ulcerative Colitis Mild

Start: 2025-05-27End: 2027-07-31Target: 20Updated: 2026-07-21